We provide you with 20 years of free, institutional-grade data for MNKD stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of MNKD. Explore the full financial landscape of MNKD stock.
| Reported Date | Ticker | Type | |
|---|---|---|---|
| 2026-05-06 | MNKD | 10-Q | Url |
| 2026-02-26 | MNKD | 10-K | Url |
| 2025-11-05 | MNKD | 10-Q | Url |
| 2025-08-06 | MNKD | 10-Q | Url |
| 2025-05-08 | MNKD | 10-Q | Url |
| 2025-02-26 | MNKD | 10-K | Url |
| 2024-11-07 | MNKD | 10-Q | Url |
| 2024-08-07 | MNKD | 10-Q | Url |
| 2024-05-08 | MNKD | 10-Q | Url |
| 2024-02-27 | MNKD | 10-K | Url |
| 2023-11-07 | MNKD | 10-Q | Url |
| 2023-08-07 | MNKD | 10-Q | Url |
| 2023-05-09 | MNKD | 10-Q | Url |
| 2023-02-23 | MNKD | 10-K | Url |
| 2022-11-08 | MNKD | 10-Q | Url |
| 2022-08-09 | MNKD | 10-Q | Url |
| 2022-05-05 | MNKD | 10-Q | Url |
| 2022-02-24 | MNKD | 10-K | Url |
| 2021-11-09 | MNKD | 10-Q | Url |
| 2021-08-11 | MNKD | 10-Q | Url |
| 2021-05-12 | MNKD | 10-Q | Url |
| 2021-02-25 | MNKD | 10-K | Url |
| 2020-11-04 | MNKD | 10-Q | Url |
| 2020-08-05 | MNKD | 10-Q | Url |
| 2020-05-06 | MNKD | 10-Q | Url |
| 2020-02-25 | MNKD | 10-K | Url |
| 2019-11-08 | MNKD | 10-Q | Url |
| 2019-08-07 | MNKD | 10-Q | Url |
| 2019-05-07 | MNKD | 10-Q | Url |
| 2019-02-26 | MNKD | 10-K | Url |
| 2018-11-01 | MNKD | 10-Q | Url |
| 2018-08-02 | MNKD | 10-Q | Url |
| 2018-05-09 | MNKD | 10-Q | Url |
| 2018-02-27 | MNKD | 10-K | Url |
| 2017-11-07 | MNKD | 10-Q | Url |
| 2017-08-07 | MNKD | 10-Q | Url |
| 2017-07-03 | MNKD | S-1 | Url |
| 2017-05-10 | MNKD | 10-Q | Url |
| 2017-03-16 | MNKD | 10-K | Url |
| 2016-11-09 | MNKD | 10-Q | Url |
| 2016-08-09 | MNKD | 10-Q | Url |
| 2016-05-09 | MNKD | 10-Q | Url |
| 2016-03-15 | MNKD | 10-K | Url |
| 2015-11-09 | MNKD | 10-Q | Url |
| 2015-08-10 | MNKD | 10-Q | Url |
| 2015-05-11 | MNKD | 10-Q | Url |
| 2015-03-02 | MNKD | 10-K | Url |
| 2014-11-10 | MNKD | 10-Q | Url |
| 2014-08-11 | MNKD | 10-Q | Url |
| 2014-05-12 | MNKD | 10-Q | Url |
MannKind Corporation(NASDAQ:MNKD) 
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. The company offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It...
Website: http://www.mannkindcorp.com
Founded: 1991
Full Time Employees: 232
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about MNKD stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.